Ocular Therapeutix, Inc. (OCUL)
8.93
-0.23
(-2.51%)
USD |
NASDAQ |
May 18, 10:25
Ocular Therapeutix Market Cap : 1.955B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 1.021B |
| Merck & Co., Inc. | 275.66B |
| Zevra Therapeutics, Inc. | 642.58M |
| Axsome Therapeutics, Inc. | 11.79B |
| Bristol Myers Squibb Co. | 118.22B |
Market Cap Related Metrics
| PS Ratio | 34.47 |
| PEG Ratio | -0.2294 |
| Price to Book Value | 3.362 |
| Price | 8.93 |
| Earnings Yield | -16.30% |
| PEGY Ratio | -0.2294 |